PTX 2.56% 3.8¢ prescient therapeutics limited

Ann: March 2024 Quarterly Update and Appendix 4C, page-5

  1. 96 Posts.
    lightbulb Created with Sketch. 50
    Bugger, back to 5 cents. I was hoping for some tangible details regarding the FDA meeting. Below are the last 3 announcements referencing the next steps for PTX-100. The FDA meeting timing has gone from "Q1/Q2 2024" to "Q2 2024" to no mention of the FDA meeting timing. Phase 2 trial timing has gone from "around the middle of 2024" to "ideally opening in Q3 2024". Come on Steven, it's time to deliver.


    PTX-100 Ph1b results show excellent safety & efficacy in TCL on 11/12/23
    https://hotcopper.com.au/data/attachments/6136/6136490-b3a299d8653a88b08919d8d602c34d08.jpg

    December 2023 Quarterly Update and Appendix 4C on 31/01/24
    https://hotcopper.com.au/data/attachments/6136/6136492-72004980082f43dc45e51e80690e4b95.jpg


    March 2024 Quarterly Update and Appendix 4C on 30/04/24
    https://hotcopper.com.au/data/attachments/6136/6136499-90e9fb69a20cf5e052ccc3892489c497.jpg
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
-0.001(2.56%)
Mkt cap ! $30.60M
Open High Low Value Volume
3.9¢ 3.9¢ 3.8¢ $47.91K 1.256M

Buyers (Bids)

No. Vol. Price($)
11 881755 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 150000 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.